✦ LIBER ✦

Treatment for orbital diffuse large B-cell lymphoma in an elderly patient by autologous cytokine-induced killer cells

✍ Scribed by Su-Xia Li; Hong-Li Zhu; Bo Guo; Xue-Chun Lu; Bo Yang; Yang Liu; Wei-Dong Han; Yao Wang; Shan-Qian Yao

Book ID: 105989936
Publisher: Springer
Year: 2011
Tongue: English
Weight: 173 KB
Volume: 91
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-011-1301-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical Study of Autologous Cytokine-In

Clinical Study of Autologous Cytokine-Induced Killer Cells for the Treatment of Elderly Patients with Diffuse Large B-Cell Lymphoma

✍ Xue-chun Lu; Bo Yang; Rui-li Yu; Xiao-hua Chi; Shuai Tuo; Chao-wei Tuo; Hong-li 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 470 KB

Doxorubicin-based chemotherapy for diffu

Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients : Comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage

✍ Keun-Wook Lee; Dae-Young Kim; Tak Yun; Dong-Wan Kim; Tae-You Kim; Sung-Soo Yoon; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB 👁 2 views

## BACKGROUND. Although many studies of elderly patients with non-Hodgkin lymphoma have focused on the dose intensity of chemotherapy, few studies have restricted the histologic inclusion criteria such that only patients with diffuse large B-cell lymphoma (DLCL) are considered. In the current stud

Rituximab in combination with CHOP chemo

Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Chinese patients

✍ J. M. Li; L. Wang; Y. Shen; Z. G. Xia; Y. Chen; Q. S. Chen; Y. Chen; X. Y. Zeng; 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 161 KB

Complete atrioventricular block induced

Complete atrioventricular block induced by rituximab in monotherapy in an aged patient with non-Hodgkin’s diffuse large B-cell lymphoma

✍ José Manuel Cervera Grau; Gaspar Esquerdo Galiana; Ana Belso Candela; Cristina L 📂 Article 📅 2008 🏛 Springer Milan 🌐 Spanish ⚖ 110 KB

Cost utility in the United States of rit

Cost utility in the United States of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone for the treatment of elderly patients with diffuse large B-cell lymphoma

✍ John C. Hornberger; Jennie H. Best 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 2 views

A phase II study of a THP-COP regimen fo

A phase II study of a THP-COP regimen for the treatment of elderly patients aged 70 years or older with diffuse large B-cell lymphoma

✍ Hisashi Tsurumi; Takeshi Hara; Naoe Goto; Nobuhiro Kanemura; Senji Kasahara; Mic 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 2 views

## Abstract Pirarubicin (tetrahydropyranyl adriamycin: THP) is an anthracycline drug that reportedly has fewer cardiotoxic effects than doxorubicin. A phase II study was conducted in order to determine the efficacy of a treatment regimen incorporating THP, namely THP‐COP in the treatment of elderly